| EVOLUÇÃO VIRAL EXPERIMENTAL PARA O DESENVOLVIMENTO DE ZIKV COM MAIOR POTENCIAL ONCOLÍTICO PARA CÉLULAS TUMORAIS DE GLIOBLASTOMA |
|
2024 |
| MELHORAMENTO MOLECULAR DA LECTINA ANTIVIRAL CYANOVIRIN-N CONTRA SARS-COV-2 |
|
2024 |
| AVALIAÇÃO DOS EFEITOS ONCOLÍTICOS DO VÍRUS DENGUE EM LINHAGENS DE GLIOBLASTOMA |
|
2024 |
| O PAPEL DO REGULADOR EPIGENÉTICO CBX4 DO GRUPO POLICOMBO NA MODULAÇÃO DA FUNÇÃO EFETORA DAS CÉLULAS T CD8. MOISES AGUIAR NEVES NETO,GUILHERME AFONSO MELO,THAÍS DE OLIVEIRA PASSOS,ALBERTO DE JESUS CHAGAS NETO,JOAO PEDRO DE LIMA DE OLIVEIRA,CAROLINA CALÔBA,LUIZA MENDONçA HIGA, RENATA DE MEIRELLES SANTOS PEREIRA. |
|
2024 |
| PRODUÇÃO DE PARTÍCULAS VIRAIS INFECCIOSAS A PARTIR DO PLASMÍDIO CONTENDO O CLONE INFECCIOSO PRVABC59 |
|
2024 |
| ANÁLISE DO PERFIL SINÁPTICO DE CAMUNDONGOS AFETADOS PELA SÍNDROME CONGÊNITA DO VÍRUS DA ZIKA |
|
2024 |
| Role of polycomb group 1 protein Cbx4 in CD8 T cell effector function in vivo |
|
2023 |
| Comparative analysis of neutralizing antibodies between vaccinated and infected individuals during the emergence of the delta variant in Rio de Janeiro (february to october 2021) |
|
2023 |
| EXPERIMENTAL EVOLUTION TO ENHANCE THE ONCOLITC ACTIVITY OF THE ZIKA VIRUS IN GLIOBLASTOMA CELLS IN VITRO. |
|
2023 |
| EVALUATION OF NEUTRALIZING ANTIBODIES AGAINST MONKEYPOX IN INDIVIDUALS IMMUNIZED WITH ANTI-VACCINIA VIRUS VACCINES |
|
2023 |
| MOLECULAR IMPROVEMENT OF THE ANTIVIRAL LECTIN CYANOVIRIN-N AGAINST SARS-COV-2. |
|
2023 |
| THE ANTIVIRAL LECTIN CYANOVIRIN-N INHIBITS SARS-COV-2 VARIANTS IN VITRO AND IN VIVO MODELS |
|
2023 |
| GLIOBLASTOMA MICROENVIRONMENT IS REMODELLED BY ZIKA VIRUS INFECTION IN VITRO AND IN VIVO. |
|
2023 |
| Congenital Zika virus infection impairs corpus callosum development |
|
2023 |
| Avaliação dos efeitos oncolíticos do vírus dengue em linhagens de glioblastoma |
|
2023 |
| Evolução viral experimental para potencializar a atividade oncolítica do vírus Zika em células de glioblastoma in vitro |
|
2023 |
| CONECTIVIDADE CEREBRAL NA VIDA PÓS-NATAL DE CAMUNDONGOS AFETADOS PELA SÍNDROME CONGÊNITA DO VÍRUS ZIKA |
|
2023 |
| GLIOBLASTOMA MICROENVIRONMENT IS REMODELLED BY ZIKA VIRUS INFECTION IN VITRO AND IN VIVO |
|
2022 |
| CONECTIVIDADE CEREBRAL NA VIDA PÓS-NATAL DE CAMUNDONGOS AFETADOS PELA SÍNDROME CONGÊNITA DO VÍRUS ZIKA |
|
2022 |
| AVALIAÇÃO DOS EFEITOS ONCOLÍTICOS DE FLAVIVIRUS EM LINHAGENS DE GLIOBLASTOMA. |
|
2022 |
| CELLULAR MECHANISMS OF ZIKA VIRUS INFECTION IN GLIOBLASTOMA MICROENVIRONMENT |
|
2021 |
| Dengue Virus Modulates Secretion And Post-Translational Modifications Of Alpha-Enolase in HepG2 Cells |
|
2013 |
| Proteins differentially secreted by HepG2 cells infected with dengue virus: implications for pathogenesis |
|
2010 |
| Proteins differentially secreted by HepG2 cells infected with dengue virus: implications for pathogenesis |
|
2010 |
| Secretome of HepG2 cells infected with dengue virus: Implications for pathogenesis |
|
2008 |
| A proteomic approach to study HepG2 hepatoma cell line infected by dengue virus |
|
2008 |
| Interaction between peptides derived from dengue virus capsid protein and model membranes |
|
2007 |
| Study of peptides secreted by HepG2 hepatoma cell infected with dengue virus using proteomic approach |
|
2007 |
| Identification of proteins differentially secreted by HepG2 Cells infected with Dengue Virus through a Proteomic approach |
|
2006 |
| Identification of proteins differentially secreted by HepG2 Cells infected with Dengue Virus through a Proteomic approach |
|
2006 |
| Identification of proteins differentially secreted by HepG2 cells infected with dengue virus through a proteomic approach. |
|
2006 |
| Proteomics analysis of proteins differentially secreted by HepG2 cells infected with dengue virus |
|
2005 |
| Mass spectrometry analysis of peptides secreted by HepG2 hepatoma cells infected with dengue virus 2. |
|
2005 |
| Proteomic Analysis of Proteins Differentially Secreted by HepG2 Cells Infected With Dengue Virus |
|
2005 |
